Compugen CGEN
NASDAQ CGEN
$2.38 +0.03 (+1.28%)
At close: Sep 30, 2026 · 4:00 PM EDT

Compugen (CGEN) EBITDA Margin (2009 - 2010)

Updated

Compugen (CGEN) reported EBITDA Margin of 43.70% for FY2025, up 95.40 percentage points from -51.70% in FY2024.

Analysis

Compugen (CGEN) EBITDA Margin (2009 - 2010) Analysis & Trends

Dating back to FY2009, Compugen's EBITDA Margin record includes 14 years.

  • EBITDA Margin has a five-year change of +1582.75 percentage points (FY2020 to FY2025).
  • The FY2025 figure ranks as the highest annual EBITDA Margin in data going back to FY2009.
  • According to Business Quant data, EBITDA Margin came in at -51.70% in FY2024 (-14.29 pp), -37.41% in FY2023 (+427.82 pp), -465.23% in FY2022 (+111.66 pp) and -576.88% in FY2021 (+962.17 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 35.95%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 49.01%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 6.02%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 33.11%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 46.01%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -124.26%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 39.16%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 39.10%
10 Compugen 225.04 Mn -148.05 Mn -92,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2010 -1,184.21%
Dec 31, 2009 -7,756.00%
API Access

Compugen EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CGEN&period=max&api_key=YOUR_API_KEY